Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
Holders of 5% or more of ORGO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Organogenesis Holdings Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ades Alan A. | 13D/A | 17.60%22.3M shares | −0.20 ppfrom 17.80% | Jan 3, 20253 filings | Jun 26, 2025 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 9.90%12.5M shares | – | Feb 11, 20251 filing | Feb 11, 2025 | SEC |
| Nussdorf Glenn H | 13D/A | 9.70%12.2M shares | – | Nov 3, 20251 filing | Nov 3, 2025 | SEC |
| First Light Asset Management, LLC | 13G | 6.55%8.31M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Organogenesis Holdings Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 20255:40 PM ET | Nussdorf Glenn Hand 2 others | 13D/A | 9.70%12.2M shares | – | May 14, 2025 | SEC |
| Aug 14, 20254:33 PM ET | First Light Asset Management, LLCand 1 other | 13G | 6.55%8.31M shares | New | Jun 30, 2025 | SEC |
| Jun 26, 20256:24 PM ET | Ades Alan A.and 13 others | 13D/A | 17.60%22.3M shares | −0.20 ppfrom 17.80% | Jun 24, 2025 | SEC |
| Feb 11, 20254:00 PM ET | Soleus Capital Master Fund, L.P.and 5 others | 13G/A | 9.90%12.5M shares | – | Dec 31, 2024 | SEC |
| Jan 13, 20255:05 PM ET | Ades Alan A.and 13 others | 13D/A | 17.80%22.3M shares | 0.00 ppfrom 17.80% | Jan 9, 2025 | SEC |
| Jan 3, 20255:18 PM ET | Ades Alan A.and 13 others | 13D/A | 17.80%22.3M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Organogenesis Holdings Inc. shares.
No Form 144 notices for Organogenesis Holdings Inc. are on file.